|
|
|
|
|
|
|
|
|
|
|
30.05.25 - 12:33
|
Cresco Labs Continues Track Record of Delivering Strong Operating Cash Flow (Business Wire)
|
|
|
Q1 operating cashflow of $30 millionCHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America's most popular brands and the operator of Sunnyside dispensaries, today released its financial and operating results for the first quarter ended and year ended March 31, 2025. All financial information presented in this release is reported in accordance with U.S. GAAP and in U.S. dollars, unless otherwise indicated, and is available on the Company's investor website, here.
First Quarter 2025 Highlights
First quarter revenue of $166 million. First quarter operating cash flow of $30 million and Free Cash Flow1 of $25 million.
Gross profit of $79 million. Adjusted gross profit1 of $82 million; and an Adjusted gross margin1 of 49% of revenue.
SG&A of $58 million or 35% of revenue.
Net loss of $15 million.
First quarter Adjusted EBITDA1 of $36 million and Adjusted EBITDA margin1...
|
|
|
29.05.25 - 12:33
|
Cresco Labs Announces Updated First Quarter 2025 Earnings Date (Business Wire)
|
|
|
CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), announced today that it will file its first quarter interim financial statements and MD&A on Friday, May 30, 2025.
Over the past three weeks, the Company has worked closely with its independent auditors to complete their review of the financial statements. The Company is pleased to report that the review was completed with no material changes from what was prepared for presentation on May 9th and looks forward to hosting a conference call and webcast to discuss its financial results.
Event: Cresco Labs First Quarter 2025 Earnings Conference Call
Date: Monday, June 2, 2025
Time: 8:30 am ET
Webcast: LINKConference Call Registration: LINKDial-in: 1-833-470-1428 (US Toll Free), 1-404-975-4839 (US Local)
Access Code: 671160
Archived access to the webcast will be available for one year on the Cresco Labs investor relations website.
About Cresco Labs Inc.
Cresco Labs' mission is to normalize and profess...
|
|
|
|
|
08.05.25 - 23:03
|
Cresco Labs Announces Rescheduling of First Quarter 2025 Earnings Release and Conference Call (Business Wire)
|
|
|
CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”) today announced that the earnings call originally scheduled for May 9, 2025 will be postponed to provide additional time to complete procedures for the review of its first quarter interim financial statements. The Company will announce the rescheduled earnings call date once it has been determined but expects to host the earnings call and file its first quarter interim financial statements on or before the required filing date of May 30, 2025.
About Cresco Labs Inc.
Cresco Labs' mission is to normalize and professionalize the cannabis industry through a CPG approach to building national brands and a customer-focused retail experience, while acting as a steward for the industry on legislative and regulatory-focused initiatives. As a leader in cultivation, production and branded product distribution, the Company is leveraging its scale and agility to grow its portfolio of brands that include Cresco,...
|
|
|
29.04.25 - 12:36
|
Cresco Labs to Report First Quarter 2025 Financial Results on May 9, 2025 (Business Wire)
|
|
|
CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America's most popular brands and the operator of Sunnyside dispensaries, today announced it will report financial results for the first quarter ended March 31st, 2025 on Friday, May 9, 2025 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights.
Event: Cresco Labs First Quarter 2025 Earnings Conference Call
Date: Friday, May 9, 2025
Time: 8:30 am ET
Webcast: LINKConference Call Registration: LINKDial-in: 1-833-470-1428 (US Toll Free), 1-404-975-4839 (US Local)
Access Code: 671160
Archived access to the webcast will be available for one year on the Cresco Labs investor relations website.
About Cresco Labs Inc.
Cresco Labs' mission is to normalize and professionalize the cannabis industry through a CPG approach to building n...
|
|
|
|
|
|
|
|
|
12.03.25 - 12:03
|
Cresco Labs′ Disciplined Strategy Drives Record Cash Flow in 2024 Financial Results (Business Wire)
|
|
|
Record full year operating cashflow of $132 million, an increase of 126% from the prior year period
CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America's most popular brands and the operator of Sunnyside dispensaries, today released its financial and operating results for the fourth quarter and year ended December 31, 2024. All financial information presented in this release is reported in accordance with U.S. GAAP and in U.S. dollars, unless otherwise indicated, and is available on the Company's investor website, here.
Fiscal Year 2024 Highlights
Revenue of $724 million. Record operating cash flow of $132 million and Free Cash Flow1 of $114 million.
Gross profit of $364 million. Adjusted gross profit1 of $374 million; and an Adjusted gross margin1 of 52% of revenue, a 270 bps improvement year-over-year.
SG&A of $221 million. Reduced Adjusted SG&A1 by 12% year...
|
|
|
03.03.25 - 12:36
|
Cresco Labs to Report Fourth Quarter 2024 Financial Results on March 12, 2025 (Business Wire)
|
|
|
CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America's most popular brands and the operator of Sunnyside dispensaries, today announced it will report financial results for the fourth quarter and year ended December 31st, 2024 on Wednesday, March 12, 2025 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights.
Event: Cresco Labs Fourth Quarter 2024 Earnings Conference Call
Date: Wednesday, March 12, 2025
Time: 8:30 am ET
Webcast: LINKConference Call Registration: LINKDial-in: 1-833-470-1428 (US Toll Free), 1-404-975-4839 (US Local)
Access Code: 680910
Archived access to the webcast will be available for one year on the Cresco Labs investor relations website.
About Cresco Labs Inc.
Cresco Labs' mission is to normalize and professionalize the cannabis industry through a ...
|
|
|
|
|
|
|
|
|
|
|
16.10.24 - 20:54
|
Cannabis Debt Looms For These Weed Giants: Heres How Some Tackled Their Financial Challenges (Benzinga)
|
|
|
That said, Green Market Report's Debra Borchardt took a closer look at how she called it "a tsunami of debt headed straight for the cannabis industry," or approximately $1.83 billion of the debt that's due by 2026 that many public marijuana operators opted for earlier as they lacked much-needed capital.Curaleaf Holdings, Inc. (OTC: CURLF), Cresco Labs (OTC: CRLBF), Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) and Verano Holdings (OTCQX: VRNOF) are about to face substantial debt maturities in 2026. Ascend Wellness, Green Thumb and Terrascend dealt with thier respective debts, at least for now.
read more...
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
